Join us !

Portugal Medical Cannabis 2019 is organized by the newly created Portuguese Observatory of Cannabis Medicinal, a nonprofit association of Scientific Nature, which aims to study cannabis and its derivatives for the benefit of patients.

The event is coordinated by the same team of Lisbon Medical Cannabis 2018

Some facts about the 2018 edition


AustraliaBelgiumBrazilBulgariaCanadaFranceGermanyIsraelMaltaNetherlandsPortugalSloveniaSpainSwitzerlandUnited KingdomUkraineUruguai

Feedback from 2018 Sponsors

Tilray was proud to partner with Portugal’s first medical cannabis conference as we strongly believe that collaboration between key stakeholders — patients, health-care practitioners, policy-makers, industry and academics – will lead to safe access for patients in-need in Portugal and around the world.

Philippe Lucas

Philippe LucasVice President, Global Patient Research & Access - Tilray

The Lisbon Medical Cannabis conference was extremely interesting and helpful. There were speakers from different fields and all of them tried to present their most recent findings. Furthermore, the speakers presented their views and opinions on how the Cannabis legal and economic framework will develop over the next few years in Europe. Moreover, the attendees had the chance to ask pertinent questions, which contributed to enrich the discussion. It was definitely a great experience.

André Oliveira

André OliveiraBusiness Development Manager & Business Analyst - Ferraz Lynce

Sponsoring our conference will be a unique opportunity to meet specialists, physicians, patients, pharmacists, researchers, investors, lawyers and other important stakeholders to enter the cannabis markets in Portugual and Europe.

Sponsoring Portugal Medical Cannabis 2019

By sponsoring this event, your company will enjoy greater visibility and recognition in the conferences and Workshops of both facilities, in Lisbon and Oporto.

“Até ao final do ano, teremos a lei necessária em Portugal para regular, desde o cultivo até à dispensa, os medicamentos à base de canábis”, disse a presidente do Infarmed, Maria do Céu Machado, à margem da Primeira Conferência Portuguesa sobre Canábis Medicinal – “Lisbon Medical C